INTERNATIONAL PATENT: BLOOD CELL TECHNOLOGIES, LLC FILES APPLICATION FOR "INHIBITORS OF BILIVERDIN REDUCTASE B (BLVRB)"

GENEVA, April 1 -- BLOOD CELL TECHNOLOGIES, LLC (9 Shipyard LaneSetauket, New York 11733-3038) filed a patent application (PCT/US2024/045089) for "INHIBITORS OF BILIVERDIN REDUCTASE B (BLVRB)" on Sep 04, 2024. With publication no. WO/2025/064210, the details related to the patent application was published on Mar 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BAHOU, Wadie (c/o Blood Cell Technologies9 Shipyard LnSetauket, New York 11733-3038), NESBITT, Natasha Monic (c/o Blood Cell Technologies9 Shipyard LaneSetauket, New York 11733-3038), ARALDI, Gian Luca (c/o Blood Cell Technologies9 ...